Skip to main content

$0.009 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
2 July 2025 at 11:55am
Register to track CPH and receive email alerts.

Halucenex Continues to Make Progress ahead of Clinical Trial

StockBot

416,823 posts

CPH released this announcement to the ASX on 4 August 2021, 9:45. The announcement is not marked as price sensitive, and is 3 page(s) in length and 148.86kb in size.

You can view all announcements from CPH and see how they appear on a price chart on the announcements page.

At the date of this announcement, CPH was 0.959% short sold according to ASIC data. It was ranked the 183rd most shorted stock on the ASX. It remains ranked 501st as of the latest reported data (08 June 2023).

Other Recent Announcements from CPH
Notification regarding unquoted securities - CPH 9 June 2023, 16:23
LOI to Import MDMA & Psilocybin Treatments to Australia 9 June 2023, 9:42
Application for quotation of securities - CPH 8 June 2023, 18:23
Halucenex Continues to Make Progress ahead of Clinical Trial 4 August 2021, 9:45
Quarterly Update & Appendix 4C 2 August 2021, 8:22
Exercise of Options 30 July 2021, 19:04
Application for quotation of securities - CPH 30 July 2021, 18:36
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CPH and receive email alerts.